Adverse Effects of Dupilumab for Chronic Rhinosinusitis With Nasal Polyposis: Real-World Single Institution Experience
{{output}}
Objective: Phase III trials have shown that dupilumab is an effective and well-tolerated adjunct treatment for patients with uncontrolled chronic rhinosinusitis with nasal polyps (CRSwNP). However, real-world data pertaining to t... ...
